CHWY vs IDXX vs CAG Stock Comparison

Chewy, Idexx Laboratories and Conagra Brands Prices as of Nov 13, 2026 Peers: Industry group
1 more company in this comparison (GIS) Create a free account to keep reading and compare up to 10 companies.
CHWY Chewy, Inc.
$22.51 +8.0% 1M -32.8% 1Y
Market cap
$8.79B
P/E
32.1x
Revenue (TTM)
$13.07B
Div. yield
–
Packaged Foods Consumer Staples
1 win
CAG Conagra Brands Inc.
$14.73 +6.3% 1M -15.5% 1Y
Market cap
$7.27B
P/E
–
Revenue (TTM)
$11.24B
Div. yield
–
Packaged Foods Consumer Staples
3 wins

Head to Head

11 decided of 12

Idexx Laboratories leads on 7 of the 12 questions below (Idexx Laboratories 7, Conagra Brands 3, Chewy 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCHWYIDXXCAGLeader
Larger companyMarket capitalisation $8.79B $55.34B $7.27B IDXX
Cheaper on earningsLower P/E, profitable companies only 32.1x 46.8x -3.8x CHWY
Cheaper on forward earningsLower price / next fiscal year consensus EPS 30.0x 44.6x 9.8x CAG
Faster revenue growthRevenue growth, trailing twelve months +5.9% +11.9% -1.8% IDXX
More profitableNet margin, trailing twelve months 2.1% 25.4% -17.0% IDXX
Better return on capitalReturn on invested capital — 45.4% -12.3% IDXX
Less leveragedLower net debt / EBITDA 0.0x 0.4x -5.6x CAG
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -32.8% +0.4% -15.5% IDXX
Better 5-year returnAnnualised price return, 5 years -21.8%/yr +2.3%/yr -14.5%/yr IDXX
Less volatileAnnualised volatility, 1 year 47.7% 36.2% 32.6% CAG
Higher overall scoreMean of the five percentile scores vs peers 70/100 76/100 43/100 IDXX

Percentile Scorecard

CHWYIDXXCAG

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCHWYIDXXCAG
Valuation 56 #21 of 46 74 #175 of 660 73 #13 of 46
Growth 90 #5 of 42 70 #184 of 619 2 #41 of 42
Profitability 60 #17 of 41 98 #12 of 595 20 #33 of 41
Financial Health 57 #21 of 48 46 #371 of 683 30 #34 of 48
Shareholder Returns 85 #6 of 34 94 #30 of 459 88 #5 of 34
Overall 70 76 43
  • CHWY ranked among 48 companies in Branded Foods
  • IDXX ranked among 695 companies in Pharmaceuticals and Biotechnology
  • CAG ranked among 48 companies in Branded Foods

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCHWYIDXXCAGSPY
1 month +8.0%+33.1%+6.3% -2.0%
3 months +0.4%+27.8%-5.7% -2.8%
6 months +5.8%+33.2%+9.7% +2.0%
Year to date -31.9%+4.1%-14.9% +10.6%
1 year -32.8%+0.4%-15.5% +12.2%
3 years +11.6%+55.0%-47.4% +68.1%
3 years, per year +3.7%+15.7%-19.3% +18.9%
5 years -70.7%+12.1%-54.3% +61.4%
5 years, per year -21.8%+2.3%-14.5% +10.1%
10 years —+545.1%-57.8% +248.5%
10 years, per year —+20.5%-8.3% +13.3%

Risk

MeasureCHWYIDXXCAGSPY
Volatility, 1Y 47.7%36.2%32.6% 13.6%
Downside volatility, 1Y 48.1%32.6%31.9% 13.9%
Beta vs S&P 500, 1Y 0.820.84-0.33 1.00
Return / volatility, 1Y -0.690.01-0.47 0.90
Max drawdown, 5Y -80.3%-50.9%-69.3% -25.4%
From 52-week high -36.4%-8.1%-26.4% -3.2%
52-week high $35.37$766.68$20.02 $779.14
52-week low $17.51$504.70$12.58 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCHWYIDXXCAG
P/E now vs peer median 33.4xmedian 18.9x 47.0xmedian 17.0x -3.7xmedian 18.9x
P/S now vs peer median 0.7xmedian 0.9x 11.9xmedian 8.4x 0.6xmedian 0.9x
EV/EBITDA now vs peer median 19.1xmedian 12.8x 33.7xmedian 14.6x -11.0xmedian 12.8x
P/FCF now vs peer median 15.9xmedian 13.7x 42.6xmedian 19.0x 7.4xmedian 13.7x
P/B now vs peer median 24.4xmedian 1.6x 29.7xmedian 2.0x 1.1xmedian 1.6x
PEG now vs peer median 0.44median 0.70 3.10median 0.43 0.07median 0.70

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCHWYIDXXCAG
Revenue $13.07B $4.66B $11.24B
Gross profit $3.91B $2.92B $2.68B
Operating income $328.20M $1.51B -$1.71B
Net income $273.70M $1.18B -$1.91B
Free cash flow $568.10M $1.30B $877.00M
R&D – $266.87M –
EPS (diluted) $0.67 $14.96 $-3.97
Cash & equivalents $611.00M $197.54M $371.60M
Total debt $591.70M $848.88M $7.76B
Shares (diluted) 410.10M 79.05M 480.00M
Enterprise value $6.08B $54.56B $6.58B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCHWYIDXXCAG
P/E 33.4x 47.0x -3.7x
P/FCF 15.9x 42.6x 7.4x
P/Operating cash flow 12.6x 39.1x 5.5x
P/S 0.7x 11.9x 0.6x
P/B 24.4x 29.7x 1.1x
P/Tangible book 40.9x 31.7x 1.5x
EV/EBITDA 19.1x 33.7x -11.0x
EV/EBIT 27.5x 37.3x -8.4x
EV/Revenue 0.7x 12.0x 1.3x
EV/FCF 15.9x 43.1x 15.2x
EV/Operating cash flow 12.6x 39.6x 11.3x
PEG (3Y EPS CAGR) 0.44 3.10 0.07

Growth

14 metrics
MetricCHWYIDXXCAG
Revenue growth (1Y) 5.9% 11.9% -1.8%
Revenue CAGR (3Y) 6.4% 9.1% -2.9%
Gross profit growth (1Y) 7.6% 13.7% -7.9%
Gross profit CAGR (3Y) 8.5% 10.8% -7.4%
Operating income growth (1Y) 102.0% 15.3% -230.3%
Operating income CAGR (3Y) 139.1% 11.8% -39.7%
Net income growth (1Y) 81.1% 15.1% -363.6%
Net income CAGR (3Y) 73.8% 12.8% -59.7%
EPS growth (1Y) 89.2% 17.4% -324.1%
EPS CAGR (3Y) 76.8% 15.1% -55.5%
Operating cash flow growth (1Y) 17.3% 30.4% -17.3%
Operating cash flow CAGR (3Y) 10.9% 19.6% 2.8%
Free cash flow growth (1Y) 22.7% 35.3% -22.4%
Free cash flow CAGR (3Y) 18.6% 24.2% 6.1%

Profitability

14 metrics
MetricCHWYIDXXCAG
Gross margin 29.9% 62.7% 23.8%
EBITDA margin 3.6% 35.7% -11.6%
Operating margin 2.5% 32.3% -15.2%
Pretax margin 2.7% 31.7% -16.7%
Net margin 2.1% 25.4% -17.0%
FCF margin 4.3% 28.0% 8.4%
Operating cash flow margin 5.5% 30.4% 11.4%
Return on equity 69.0% 67.9% -29.9%
Return on assets 7.8% 33.1% -10.9%
Return on invested capital – 45.4% -12.3%
Return on capital employed 24.9% 65.2% -11.8%
Asset turnover 3.7x 1.3x 0.6x
Cash conversion (OCF / net income) 2.6x 1.2x -0.6x
Stock comp / revenue 2.3% 1.4% 0.4%

Financial Health

11 metrics
MetricCHWYIDXXCAG
Debt / assets 15.8% 22.9% 43.8%
Debt / equity 1.6x 0.5x 1.2x
Net debt / EBITDA 0.0x 0.4x -5.6x
Debt / FCF 1.0x 0.7x 8.2x
Liabilities / assets 90.1% 49.6% 63.8%
Equity / assets 9.9% 50.4% 36.2%
Interest coverage – 43.5x –
Current ratio 0.8x 1.2x 1.1x
Quick ratio 0.4x 0.7x 0.3x
Cash ratio 0.3x 0.2x 0.1x
Altman Z-score 4.83 23.56 1.05

Shareholder Returns

7 metrics
MetricCHWYIDXXCAG
Dividend yield – – 7.1%
Net buyback yield 5.6% 1.7% 1.4%
Shareholder yield 5.6% 1.7% 8.4%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCHWYIDXXCAG
Forward P/E 30.0xFY2026 44.6xFY2026 9.8xFY2026
EPS, next fiscal year $0.75FY2026 $15.78FY2026 $1.50FY2026
EPS growth, next FY +44.2%FY2026 +20.6%FY2026 -12.8%FY2026
EPS growth, the year after +49.3% +12.3% -2.7%
Revenue, next fiscal year $12.87BFY2026 $5.03BFY2026 $10.36BFY2026
Revenue growth, next FY +2.1%FY2026 +17.0%FY2026 -8.2%FY2026
Revenue growth, the year after +5.5% +0.4% +1.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCHWYIDXXCAG
Held by institutions 100.0% 93.6% 88.4%
Institutions holding 513 1,292 787
Change in shares held, QoQ -0.4% +4.1% +3.9%
Institutions buying 278 590 487
Institutions selling 156 496 208
Buyers to sellers 1.78 1.19 2.34

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CHWYIDXXCAG
CHWY 1.00 0.33 0.20
IDXX 0.33 1.00 0.19
CAG 0.20 0.19 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CHWY, IDXX and CAG?

Idexx Laboratories (IDXX) is the largest by market capitalisation: Chewy (CHWY) $8.79B, Idexx Laboratories (IDXX) $55.34B, Conagra Brands (CAG) $7.27B.

Which stock is cheaper, CHWY, IDXX and CAG?

Chewy (CHWY) trades on the lowest price-to-earnings ratio (Chewy (CHWY) 32.1x, Idexx Laboratories (IDXX) 46.8x, Conagra Brands (CAG) -3.8x). On next year's consensus earnings, Conagra Brands (CAG) is cheapest (Chewy (CHWY) 30.0x, Idexx Laboratories (IDXX) 44.6x, Conagra Brands (CAG) 9.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Idexx Laboratories (IDXX) grew revenue fastest over the trailing twelve months: Chewy (CHWY) +5.9%, Idexx Laboratories (IDXX) +11.9%, Conagra Brands (CAG) -1.8%.

Which company is more profitable?

Idexx Laboratories (IDXX) has the highest net margin (Chewy (CHWY) 2.1%, Idexx Laboratories (IDXX) 25.4%, Conagra Brands (CAG) -17.0%). On return on invested capital, Idexx Laboratories (IDXX) leads (Idexx Laboratories (IDXX) 45.4%, Conagra Brands (CAG) -12.3%).

Which stock has performed better?

Over the past year Idexx Laboratories (IDXX) returned the most: Chewy (CHWY) -32.8%, Idexx Laboratories (IDXX) +0.4%, Conagra Brands (CAG) -15.5%. Over five years, Idexx Laboratories (IDXX) compounded fastest (Chewy (CHWY) -21.8%/yr, Idexx Laboratories (IDXX) +2.3%/yr, Conagra Brands (CAG) -14.5%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Conagra Brands (CAG) has been the steadiest (Chewy (CHWY) 47.7%, Idexx Laboratories (IDXX) 36.2%, Conagra Brands (CAG) 32.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CHWY, IDXX and CAG?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Idexx Laboratories (IDXX) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.